Prediction of Outcome of Non Invasive Ventilation COPD Patients by Assessment of Diaphragmatic Performance

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-90
SponsorAssiut University

About this trial

Transthoracic ultrasonographic assessment of the diaphragmatic performance as a predictor for the outcome of NIV in critically ill COPD patients with acute exacerbation.

Eligibility criteria

Qualifiers

One Hundred fifty five critically ill COPD patients admitted to respiratory intensive care unit

Diagnosis of COPD and COPD exacerbation is fulfilled according to GOLD 2022 criteria

Age>40years

Disqualifiers

Age ˂ 40 years.

Refusal to participate in the study.

Patients with morbid obesity (BMI>40).

Absolute indication for intubation like coma ,hemodynamic instability, or life threatening arrhythmia.

Trial design

Treatments tested in this trial

  • transthoracic ultrasound

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators